Image

Effect of Amitriptyline and Trifluoperazine on Patients With Functional Dyspepsia

Effect of Amitriptyline and Trifluoperazine on Patients With Functional Dyspepsia

Recruiting
18-60 years
All
Phase 2/3

Powered by AI

Overview

The goal of this clinical trial is to assess and compare the effect of amitriptyline and trifluoperazine in improving dyspeptic symptoms in patients with functional dyspepsia. It will also assess about the safety of drugs amitriptyline and trifluoperazine by recording the patient reported adverse events. The main questions it aims to answer are:

Does drug amitriptyline and trifluoperazine has any effect on patients with functional dyspepsia? What medical problems do participants have when taking drug amitriptyline and trifluoperazine? Researcher will compare drug amitriptyline and trifluoperazine to a control group taking standard first line treatment only.

Participants will:

Take drug amitriptyline 10 milligrams at night or trifluoperazine 1 milligrams twice daily every day for 8 weeks along with standard first line treatment. A third group will be taken as control arm who will be kept on standard first line treatment only for 8 weeks. After that all three groups will be kept only on standard first line treatment for an additional 4 weeks. They will visit the hospital 4 weekly, and their symptoms will be assessed by a 5-point Likert Scale at baseline, week 4, 8, and 12. Additionally, patient reported adverse events will be documented.

Eligibility

Inclusion Criteria:

  • Age 18 years or more
  • Patients with FD diagnosed according to ROME IV criteria
  • Patients who are willing to sign informed written consent

Exclusion Criteria:

  • Structural lesion in endoscopy and positive CLO test
  • Patients scoring 1 or 2 on the 5-point Likert scale for all four dyspepsia symptoms
  • History of malignancy, liver and biliary tract disease, diabetes mellitus, chronic kidney disease
  • Major medical and psychiatric disorders
  • Previous history gastrointestinal surgery
  • Any patient with ongoing treatment with antidepressants or antipsychotics
  • Any history of hypersensitivity, adverse effect, or ineffectiveness with amitriptyline or trifluoperazine
  • Patients for whom Amitriptyline and Trifluoperazine are contraindicated
  • Elderly patients> 60 years
  • Pregnancy and breastfeeding

Study details
    Functional Dyspepsia

NCT07008235

Md. Moktadirul Hoque Shuvo

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.